Steel Partners Proposes $18.00 Per Share Acquisition of InMode
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: stocktwits
- Acquisition Proposal: Steel Partners has proposed to acquire 51% of InMode's shares at $18.00 each, representing a 29% premium over the closing price on January 23, 2026, indicating confidence in InMode's future potential.
- Funding Source: The proposal will be fully funded through existing cash and borrowing capacity, with no financing contingencies, demonstrating Steel Partners' strong commitment and financial capability for the transaction.
- Management Interaction: Steel Partners attempted to engage in private discussions with InMode's management but was rebuffed, indicating a potential move to present a binding proposal directly to shareholders, reflecting disappointment in management communication.
- Shareholder Return Concerns: Steel Partners criticized InMode for failing to effectively return capital to shareholders despite having significant cash reserves and no debt, highlighting concerns over corporate governance and shareholder value creation.
Analyst Views on INMD
Wall Street analysts forecast INMD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INMD is 17.33 USD with a low forecast of 15.00 USD and a high forecast of 21.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
1 Buy
4 Hold
0 Sell
Hold
Current: 15.250
Low
15.00
Averages
17.33
High
21.00
Current: 15.250
Low
15.00
Averages
17.33
High
21.00
About INMD
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
